On February 12, 2026, Barington Firms Administration disclosed a brand new place in Chemed (NYSE:CHE), buying 13,000 shares in an estimated $5.56 million commerce.
In keeping with an SEC submitting dated February 12, 2026, Barington Firms Administration established a brand new place in Chemed, buying 13,000 shares. The quarter-end worth of the stake was $5.56 million.
-
This new place accounts for 3.65% of Barington Firms Administration’s reportable U.S. fairness property following the submitting.
-
High 5 holdings after the submitting:
-
NYSE: M: $28.66 million (18.8% of AUM)
-
NASDAQ: MATW: $26.12 million (17.1% of AUM)
-
NYSE: VSCO: $23.02 million (15.1% of AUM)
-
NYSE: BILL: $21.27 million (14.0% of AUM)
-
NYSE: GIL: $15.94 million (10.5% of AUM)
-
-
As of February 12, 2026, shares of Chemed had been priced at $463.95, down 15.18% over the prior yr and trailing the S&P 500 by 28.09 proportion factors.
|
Metric |
Worth |
|---|---|
|
Value (as of market shut February 12, 2026) |
$463.95 |
|
Market capitalization |
$6.76 billion |
|
Income (TTM) |
$2.53 billion |
|
Web earnings (TTM) |
$278.81 million |
-
Chemed operates by way of two important segments: VITAS, which supplies hospice and palliative care providers, and Roto-Rooter, providing plumbing, drain cleansing, and water restoration providers.
-
The corporate generates income primarily from healthcare providers delivered to sufferers and from residential and industrial plumbing and upkeep options.
-
Its main prospects embody sufferers and households in want of end-of-life care, in addition to residential and industrial property homeowners requiring plumbing and associated providers.
Chemed is a diversified providers firm with a robust presence in each the healthcare and important residence providers markets. Its dual-segment mannequin permits steady income streams by serving crucial wants in hospice care and property upkeep. The corporate leverages its nationwide community, model energy, and operational experience to keep up a aggressive place in its core markets.
This transfer issues as a result of it alerts conviction in a gentle, cash-rich operator that simply hit a tough patch in sentiment, however not in solvency. Chemed generated $624.9 million in third-quarter income, up 3.1% yr over yr, however adjusted diluted EPS got here in at $5.27, down 6.6% yr over yr. GAAP EPS was harder-hit, falling 10.8% to $4.46, however that decline got here alongside continued income progress at VITAS and Roto-Rooter and ongoing share repurchases.
VITAS income climbed 4.2% to $407.7 million, with admissions up 5.6% and common every day census up 2.5%. Roto-Rooter grew income 1.1% to $217.2 million, although margins compressed. Importantly, Chemed ended the quarter with $129.8 million in money and no present or long-term debt, and it reiterated full-year steerage of $22.00 to $22.30 per share.
Inside a portfolio dominated by client and expertise names like Macy’s, Victoria’s Secret, and BILL, this 3.65% place provides defensive publicity within the very totally different fields of hospice care and important plumbing providers. Finally, long-term traders ought to concentrate on money technology, stability sheet energy, and demographic tailwinds in hospice, not a single quarter’s margin stress.
